The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..
Under his leadership, Merck has seen impressive growth for its immunotherapy blockbuster Keytruda (pembrolizumab) and other innovative treatments.
Armed with two Opdivo combinations in its arsenal, BMS is primed to take on Merck &Co/MSD’s blockbuster checkpoint inhibitor Keytruda (pembrolizumab) plus Pfizer’s TKI Inlyta (ipilimumab). ... Keytruda/Inlyta won an FDA approval in advanced RCC in
If Opdivo wins an approval for first-line gastric cancer, it could gain an advantage over Merck &Co’s (MSD) rival checkpoint inhibitor Keytruda (pembrolizumab). ... In the Keynote-062 trial, Keytruda plus chemotherapy was not found to be statistically
Merck &Co’s checkpoint inhibitor Keytruda (pembrolizumab) currently holds much of the NSCLC market, although the drug failed to show benefit in ES-SCLC when added to chemotherapy.
The company is also collaborating with Merck &Co (MSD) on a clinical trial evaluating the safety and efficacy of SRF617 in combination with Merck’s blockbuster PD-1 inhibitor Keytruda (pembrolizumab).
[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...